Stock Selection: Perplexity's picks for 2026-10-27

Perplexity picked CLS, AMD, AVGO, MU, NVDA for a 1-day horizon. Portfolio return vs SPY: +2.51%. Picks that beat SPY: 80%.

ExperimentStock Selection
ModelPerplexity
Prompt versionstock-selection-v8
Asked
Horizon1-day
Measured from2026-10-27
Measured to2026-10-28
BenchmarkSPY
StatusSettled
Portfolio return vs SPY+2.51%
Picks that beat SPY80%
Benchmark return+0.23%

The picks

RankSymbolReturnConfidencevs benchmarkCalled right
1CLS+5.98%72%+5.75%Yes
2AMD+1.85%66%+1.62%Yes
3AVGO+1.49%64%+1.25%Yes
4MU+4.34%61%+4.11%Yes
5NVDA+0.03%58%-0.20%No

The model's market view

Risk appetite is improving intraday as AI infrastructure, semiconductors, and memory names rebound on strong AI capex signals, Anthropic-related financing news, and upbeat earnings. The one-day edge favors high-beta AI/semiconductor exposure over SPY, though positioning remains vulnerable to profit-taking ahead of major technology earnings and the Federal Reserve decision.

Why each pick

CLS

Celestica is the strongest one-day momentum candidate after a major Q3 beat, raised 2026 guidance, and a 2027 outlook of roughly $40 billion in revenue that was well above consensus. The stock opened sharply higher and was recently quoted at $270.24, up 9.56% in the regular session at 10:43 AM EDT on 2026-10-27; this is a delayed intraday quote. Its AI-infrastructure exposure and investor-day catalyst support continued relative outperformance. Risks include a large opening gap, rapid mean reversion, customer concentration, and valuation sensitivity if the AI trade fades.

AMD

AMD is benefiting from a renewed semiconductor rally and reports of a deeper strategic partnership with Meta. It was recently quoted at $551.11, up 3.73% intraday on 2026-10-27, materially ahead of SPY's roughly 0.09% gain at 10:10 AM EDT. Momentum, AI accelerator demand, and the sector-wide rebound support outperformance over one session. Risks are high valuation, crowded positioning, and a reversal if investors de-risk before Wednesday's mega-cap earnings and Fed decision.

AVGO

Broadcom has a clear incremental catalyst: Bank of America, Citi, Morgan Stanley, and Blackstone announced $63 billion in financing supporting Anthropic's purchase of Broadcom AI chips. The stock was recently quoted at $338.80, up 2.93% intraday on 2026-10-27, and the news is lifting sentiment across AI networking and custom silicon. Risks include the stock's sensitivity to AI-financing headlines and potential profit-taking after a strong prior session.

MU

Micron offers high-beta exposure to the memory-price and AI-data-center theme. It was recently quoted at $925.32, up 2.39% intraday on 2026-10-27, while peer memory names also advanced on expectations of sustained memory-price increases. Its leverage to HBM and AI server demand makes it likely to outperform SPY if the semiconductor rebound persists. Risks include extreme volatility, valuation, and sensitivity to any slowdown in AI capex or memory pricing expectations.

NVDA

Nvidia remains the core AI-infrastructure beneficiary and is supported by reports of expanded Meta collaboration, a planned $3 billion investment in Meta's equity offering, tight GPU supply, and renewed AI sentiment after Anthropic's IPO filing. It was recently quoted at $216.995, up 0.46% intraday on 2026-10-27. The pick relies on continued rotation into AI leaders, but its smaller intraday gain than AMD and AVGO makes it the lower-conviction selection. Risks include valuation, headline-driven volatility, and broader de-risking before the Fed decision.

Other models on the same run

ModelPicksPortfolio return vs SPYPicks that beat SPY
Claude Sonnet 5.5GEV, NVDA, QQQ, XLV, SMH+0.12%60%
Gemini 3.6 Flash HighAMD, AVGO, TSM, NVDA, AMZN+0.66%80%
Grok 4.7CLS, SOFI, AVGO, BE, AMD+1.92%80%
Muse Spark 1.1SOFI, UPS, STX, HOOD, V-1.01%60%
GPT-6SOFI, CLS, CDNS, RCL, UPS+1.80%80%
DeepSeekSTX, HOOD, V, AVGO, CLS-0.16%60%

Written up on ForecastNest Insights: Stock Selection: Perplexity's picks for 2026-10-27.

ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.